Skip to main content
Publications
Rebordosa C, Thomsen RW, Tave AK, Madsen M, Beachler DC, Martinez D, Garcia-Esteban R, Plana E, Tormos A, Farsani SF, Perez-Gutthann S, Pladevall-Vila M. Liver, renal, genitourinary, and diabetic ketoacidosis risks among new users of empagliflozin versus DPP-4 inhibitors in patients with type 2 diabetes: post-authorisation safety study based on multinational cohorts. Diabetes Obes Metab. 2024 Apr;26(4):1291-304. doi: 10.1111/dom.15429
Sauchelli S, Arcelus J, Sanchez I, Riesco N, Jimenez-Murcia S, Granero R, Gunnard K, Banos R, Botella C, de la Torre R, Fernandez-Garcia JC, Fernandez-Real JM, Fruhbeck G, Gomez-Ambrosi J, Tinahones FJ, Casanueva FF, Menchon JM, Fernandez-Aranda F. Physical activity in anorexia nervosa: how relevant is it to therapy response? Eur Psychiatry. 2015 Nov;30(8):924-31. doi: 10.1016/j.eurpsy.2015.09.008